These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 6371017)

  • 21. Advanced ovarian carcinoma. Factors influencing survival.
    Klein B; Falkson G; Smit CF
    Cancer; 1985 Apr; 55(8):1829-34. PubMed ID: 3978568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of mono- and polychemotherapy in patients with advanced ovarian cancer].
    Khasanova DT; Kotova DG
    Vopr Onkol; 1984; 30(3):67-71. PubMed ID: 6369776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraperitoneal therapy for advanced ovarian cancer: will it become standard care?
    Bankhead C
    J Natl Cancer Inst; 2006 Apr; 98(8):510-2. PubMed ID: 16622116
    [No Abstract]   [Full Text] [Related]  

  • 24. Second line platinum-based intraperitoneal chemotherapy for advanced ovarian cancer.
    Milczek T; Klasa-Mazurkiewicz D; Emerich J; Kobierski J
    Acta Obstet Gynecol Scand; 2009; 88(4):463-7. PubMed ID: 19235559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer. Gruppo Interegionale Cooperativo Oncologico Ginecologia.
    Lancet; 1987 Aug; 2(8555):353-9. PubMed ID: 2886821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of 2 different forms of chemotherapy on remission in patients with advanced ovarian cancer].
    Krommer K; Keller G; Csaba I; Garadnay B; Göcze P
    Zentralbl Gynakol; 1990; 112(17):1105-10. PubMed ID: 2264421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized trial comparing high-dose cisplatin with low-dose cisplatin and chlorambucil in advanced ovarian carcinoma.
    Wiltshaw E; Evans B; Rustin G; Gilbey E; Baker J; Barker G
    J Clin Oncol; 1986 May; 4(5):722-9. PubMed ID: 3517243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic effectiveness of various combination chemotherapy protocols in advanced epithelial ovarian cancer].
    Petru E; Schmähl D
    Geburtshilfe Frauenheilkd; 1986 Nov; 46(11):783-9. PubMed ID: 3803871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission.
    Tournigand C; Louvet C; Molitor JL; Fritel X; Dehni N; Sezeur A; Pigné A; Cady J; Milliez J; de Gramont A
    Gynecol Oncol; 2003 Nov; 91(2):341-5. PubMed ID: 14599864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.
    Covens A; Carey M; Bryson P; Verma S; Fung Kee Fung M; Johnston M
    Gynecol Oncol; 2002 Apr; 85(1):71-80. PubMed ID: 11925123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a role for intraperitoneal chemotherapy in the management of ovarian cancer?
    Markman M
    Oncology (Williston Park); 2001 Jan; 15(1):93-8; discussion 103-5. PubMed ID: 11271985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemotherapy in ovarian carcinoma: present role and future prospects.
    Thigpen JT; Blessing JA; Vance RB; Lambuth BW
    Semin Oncol; 1989 Aug; 16(4 Suppl 6):58-65. PubMed ID: 2669138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraperitoneal chemotherapy in the treatment of ovarian cancer.
    Markman M
    Ann Med; 1996 Aug; 28(4):293-6. PubMed ID: 8862681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of chemotherapy in the management of epithelial ovarian cancer.
    Reed NS; Sadozye AH
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):139-47. PubMed ID: 15757446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer.
    Yen MS; Juang CM; Lai CR; Chao GC; Ng HT; Yuan CC
    Int J Gynaecol Obstet; 2001 Jan; 72(1):55-60. PubMed ID: 11146078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic and therapeutic value of second-look laparotomy in advanced ovarian cancer.
    Bertelsen K; Hansen MK; Pedersen PH; Larsen G; Nyland M; Jacobsen M; Andersen JE
    Br J Obstet Gynaecol; 1988 Dec; 95(12):1231-6. PubMed ID: 3224088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.
    Ozols RF; Bookman MA; du Bois A; Pfisterer J; Reuss A; Young RC
    Gynecol Oncol; 2006 Oct; 103(1):1-6. PubMed ID: 16904166
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group.
    Aabo K; Adams M; Adnitt P; Alberts DS; Athanazziou A; Barley V; Bell DR; Bianchi U; Bolis G; Brady MF; Brodovsky HS; Bruckner H; Buyse M; Canetta R; Chylak V; Cohen CJ; Colombo N; Conte PF; Crowther D; Edmonson JH; Gennatas C; Gilbey E; Gore M; Guthrie D; Yeap BY
    Br J Cancer; 1998 Dec; 78(11):1479-87. PubMed ID: 9836481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
    Zhao XD; Zhang Q; Zhang Y
    Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pursuit of optimum outcomes in ovarian cancer: methodological approaches to therapy.
    Gibbs DD; Gore ME
    Drugs; 2001; 61(8):1103-20. PubMed ID: 11465872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.